Immunization Action Coalition and the Hepatitis B Coalition

IAC EXPRESS

Previous issues index

Home page

Issue Number 347            November 4, 2002

CONTENTS OF THIS ISSUE

  1. Stay calm: IAC's new website isn't replacing IAC's original website!
  2. Aventis Pasteur recalls selected lots of meningococcal vaccine
  3. Pennsylvania now requires prenatal screening for hepatitis B surface antigen
  4. New translations! Updated "Are you 11-19?" available in Spanish and Turkish
  5. CDC releases recommendations for hand hygiene in health-care settings
  6. Reminder! November 15 is deadline for abstracts for the National Immunization Conference
  7. Newly available! IOM report from the Austin Workshop on Immunization Finance is in print and online
  8. CDC announces National Diabetes Awareness Month and reports that more diabetics need to practice preventive care--including getting immunizations
  9. Fourth National HARM Reduction Conference, "Taking Drug Users Seriously," set for December 1-4

----------------------------------------------------------

Back to Top

(1 of 9)
November 4, 2002
STAY CALM: IAC'S NEW WEBSITE ISN'T REPLACING IAC'S ORIGINAL WEBSITE!

The Immunization Action Coalition (IAC) has received a number of inquiries from health professionals after the launch of our new website for the public last week. Some individuals seem to have  misunderstood this announcement to mean that the new website (http://www.vaccineinformation.org/) was going to replace IAC's original website (http://www.immunize.org/).

Not true! The new website is designed for the general public; the original website is intended primarily for health professionals. While there is some overlap between the two sites, each features unique material appropriate for its intended audience.

We apologize for any confusion and invite you to explore and bookmark both websites! Please visit both sites often!
----------------------------------------------------------

Back to Top

(2 of 9)
November 4, 2002
AVENTIS PASTEUR RECALLS SELECTED LOTS OF MENINGOCOCCAL VACCINE

On October 18, Aventis Pasteur initiated a voluntary recall of selected lots of its Menomune meningococcal polysaccharide vaccine, groups A, C, Y, W-135 combined, single-dose vials (including single-dose in five-dose packaging).

The following is from the company's Menomune website:

********************

INFORMATION ABOUT THE RECALL AND WITHDRAWAL OF MENOMUNE-A/C/Y/W-135 VACCINE (MENINGOCOCCAL POLYSACCHARIDE VACCINE, GROUPS A, C, Y, AND W-135 COMBINED)

Key Facts

  • Aventis Pasteur is voluntarily recalling 4 single-dose lots of Menomune-A/C/Y/W-135 vaccine because stability data indicated a potential for reduced protection against disease caused by serogroup A.
     
  • As a precautionary measure, Aventis Pasteur is also withdrawing all single-dose vials of Menomune-A/C/Y/ W-135 vaccine because single-dose vials may fail potency standards for serogroup A before the expiration date.
     
  • U.S. college students should not be at risk of exposure to serogroup A meningococcal disease unless they travel to certain parts of Africa or have laboratory or industrial exposure to serogroup A disease.
     
  • To the best of our knowledge, serogroup A disease does not circulate in the United States.
     
  • According to the U.S. Centers for Disease Control and Prevention, there has only been one case of serogroup A meningococcal disease in the United States in the past ten years.
     
  • Serogroups C, Y, and B are the most common strains of meningococcal disease in the United States with fewer cases of serogroup W-135. There is currently no vaccine licensed in the United States to protect against serogroup B disease.
     
  • Menomune-A/C/Y/W-135 vaccine continues to offer protection against serogroups C, Y, and W-135.
     
  • Anyone who has been vaccinated with Menomune-A/C/Y/W-135 vaccine from the recalled and withdrawn lots since January 2, 2001, and who is planning to travel to countries with a high risk of serogroup A exposure or persons with laboratory or industrial exposure to serogroup A disease should contact their health care provider to discuss revaccination.

************************

To learn more about the recall, visit the company's Menomune website at
http://www.menomune.com

To read the recall information on FDA's website, go to:
http://www.fda.gov/cber/recalls/avemeni101802.htm

For further information, call Aventis Pasteur at (800) 752-9340.
----------------------------------------------------------

Back to Top

(3 of 9)
November 4, 2002
PENNSYLVANIA NOW REQUIRES PRENATAL SCREENING FOR HEPATITIS B SURFACE ANTIGEN

Since February, Pennsylvania has required that health care providers perform a hepatitis B surface  antigen (HBsAg) screening test on all women once pregnancy is confirmed. In addition, the positive  test result must be reported to the Pennsylvania Department of Health.

To find out about current hepatitis B prenatal testing and vaccination laws for Pennsylvania and other states, visit the "Hepatitis B Prevention Mandates" web page on the website of the Immunization Action  Coalition (IAC) at http://www.immunize.org/laws/hepb.htm

To get the latest information compiled by IAC on other state mandates for vaccinations, go to: http://www.immunize.org/laws/

We depend on state health departments and other readers to help us stay informed and ensure this is  the most accurate and current information available. Please let us know when any changes occur in your state by emailing us at admin@immunize.org or calling us at (651) 647-9009.
----------------------------------------------------------

Back to Top

(4 of 9)
November 4, 2002
NEW TRANSLATIONS! UPDATED "ARE YOU 11-19?" NOW AVAILABLE IN SPANISH AND TURKISH

The Immunization Action Coalition (IAC) now has Spanish and Turkish translations of its recently revised patient-education sheet "Are You 11-19? Then You Need to be Vaccinated Against These Serious Diseases!"

IAC gratefully acknowledges the National Immunization Program of the Centers for Disease Control and Prevention for the Spanish translation and Mustafa Kozanoglu, MD, and Murat Serbest, MD, of Adana, Turkey, for the Turkish translation.

To obtain the Spanish translation in HTML format, go to:
http://www.immunize.org/catg.d/p4020-01.htm

For a camera-ready (PDF) version of the Spanish translation, go to:
http://www.immunize.org/catg.d/p4020-01.pdf

The Turkish translation is available in a camera-ready (PDF) version only at
http://www.immunize.org/catg.d/p4020tu.pdf

To obtain the English version in HTML format, go to:
http://www.immunize.org/catg.d/p4020.htm

For a camera-ready (PDF) copy of the English version, go to:
http://www.immunize.org/catg.d/11teens8.pdf
----------------------------------------------------------

Back to Top

(5 of 9)
November 4, 2002
CDC RELEASES RECOMMENDATIONS FOR HAND HYGIENE IN HEALTH-CARE SETTINGS

The Centers for Disease Control and Prevention (CDC) published "Guideline for Hand Hygiene in Health-Care Settings" in the October 25 issue of "MMWR Recommendations and Reports."

The guideline comprises the recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA [Healthcare Infection Control Practices Advisory Committee/Society for Healthcare Epidemiology of America/Association for Professionals in Infection  Control and Epidemiology/Infectious Diseases Society of America] Hand Hygiene Task Force. The summary is reprinted below:

***************************

The Guideline for Hand Hygiene in Health-Care Settings provides health-care workers (HCWs) with a  review of data regarding handwashing and hand antisepsis in health-care settings. In addition, it provides specific recommendations to promote improved hand-hygiene practices and reduce  transmission of pathogenic microorganisms to patients and personnel in health-care settings. This report reviews studies published since the 1985 CDC guideline (Garner JS, Favero MS. CDC guideline for handwashing and hospital environmental control, 1985. Infect Control 1986;7:231-43) and the 1995 APIC guideline (Larson EL, APIC Guidelines Committee. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995;23:251-69) were issued and provides an in-depth review of hand-hygiene practices of HCWs, levels of adherence of personnel to recommended handwashing practices, and factors adversely affecting adherence. New studies of the in vivo efficacy of alcohol-based hand rubs and the low incidence of dermatitis associated with their use are reviewed. Recent studies demonstrating the value of multidisciplinary hand-hygiene promotion programs and the potential role of alcohol-based hand rubs in improving hand-hygiene practices are summarized. Recommendations concerning related issues (e.g., the use of surgical hand antiseptics, hand lotions or creams, and wearing of artificial fingernails) are also included.

***************************

To obtain the complete text of the guideline online, go to: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5116a1.htm

To obtain a camera-ready (PDF format) copy of the guideline, go to:
http://www.cdc.gov/mmwr/PDF/rr/rr5116.pdf

The PDF version includes a free CDC-sponsored continuing education activity that can be completed online or submitted via U.S. mail for CME, CEU, CHES, or CNE credit. Simply read the MMWR report, answer the questions at the end of the report, and follow the instructions for submitting your answers.

HOW TO OBTAIN A FREE ELECTRONIC SUBSCRIPTION TO THE MMWR:
To obtain a free electronic subscription to the "Morbidity and Mortality Weekly Report" (MMWR), visit CDC's MMWR website at: http://www.cdc.gov/mmwr Select "Free Subscription" from the menu at  the left of the screen. Once you have submitted the required information, weekly issues of the MMWR and all new ACIP statements (published as MMWR's "Recommendations and Reports") will arrive automatically by email.
----------------------------------------------------------

Back to Top

(6 of 9)
November 4, 2002
REMINDER! NOVEMBER 15 IS DEADLINE FOR ABSTRACTS FOR THE NATIONAL IMMUNIZATION CONFERENCE

The deadline for submitting abstracts for the 37th National Immunization Conference is November 15. The conference will be held March 17-20, 2003, in Chicago.

To access the online abstract submission system, go to: http://www.cdc.gov/nip/nic/

For further information about the conference, call Suzanne Johnson-DeLeon at (404) 639-8225 or email her at nipnic@cdc.gov
----------------------------------------------------------

Back to Top

(7 of 9)
November 4, 2002
NEWLY AVAILABLE! IOM REPORT FROM THE AUSTIN WORKSHOP ON IMMUNIZATION FINANCE IS IN PRINT AND ONLINE

A new report titled "Setting the Course: A Strategic Vision for Immunization. Part 2: Summary of the Austin Workshop" was recently published by the Institute of Medicine (IOM) of the National Academies.

The report summarizes the discussions of the IOM workshop held in Austin, TX, in October 2001 and is part of the immunization finance dissemination effort associated with the release of an earlier IOM  report, "Calling the Shots: Immunization Finance Policies and Practices."

The Austin workshop report summarizes the findings of "Calling the Shots" and reviews the challenges that remain in establishing a reliable financial base for the U.S. immunization system, with specific  reference to challenges and strategies in the state of Texas.

To access the report and order it online, go to: http://www.nap.edu/catalog/10495.html

For further information, call Ryan Palugod at (202) 334-3973.
----------------------------------------------------------

Back to Top

(8 of 9)
November 4, 2002
CDC ANNOUNCES NATIONAL DIABETES AWARENESS MONTH AND REPORTS THAT MORE DIABETICS NEED TO PRACTICE PREVENTIVE CARE--INCLUDING GETTING IMMUNIZATIONS

On November 1, the Centers for Disease Control and Prevention (CDC) announced that November is  National Diabetes Awareness Month and published "Preventive-Care Practices Among Persons with Diabetes--United States, 1995 and 2001" in the Morbidity and Mortality Weekly Report (MMWR).

The announcement of National Diabetes Awareness Month says in part: "Persons with diabetes should receive pneumococcal vaccinations and annual influenza vaccinations because they are more likely than other persons to die from complications of pneumonia and influenza."

The article on preventive-care practices analyzes data on selected diabetes-related preventive-care practices, including influenza and pneumococcal coverage, gathered from the Behavioral Risk Factor Surveillance System (BRFSS) from 1995 to 2001 and compares the data against national health objectives for 2010.

The article presents data based on respondents' age, sex, race/ethnicity, education level, and access to health insurance. It states in part:

****************

From 1995 to 2001, the age-adjusted rate increased significantly for both influenza and pneumococcal vaccinations. However, in 2001, the age-adjusted rate of influenza vaccination among persons with diabetes was higher than that for pneumococcal vaccination (43.5% versus 35.0%).

The rates of influenza vaccination increased with age for both 1995 and 2001, and rates in each age group increased from 1995 to 2001; however, the increase was statistically significant only among  those aged 65-74 years. In addition, the age-adjusted rate of influenza vaccination increased significantly among men, non-Hispanic blacks, and those with a high school education.

The age-specific rate of pneumococcal vaccination increased with age in both 1995 and 2001. The rate of pneumococcal vaccination increased significantly in each age group. In addition, the age-adjusted rate increased significantly among men and women, non-Hispanic whites and non-Hispanic  blacks, Hispanics, persons at each level of education, and those with and without health insurance.

In 2001, the age-adjusted rates of the three preventive-care practices [eye examination, foot examination, and self-monitoring of blood glucose at least once daily] and the two vaccinations were  below levels recommended by the national health objectives. Rates of pneumococcal vaccination among younger persons with diabetes showed the largest difference compared with the 2010 objectives.

**********************

The editorial note finds that though the percentage of diabetics who received preventive-care services increased from 1995 to 2001, the rate of use of preventive-care practices and vaccination coverage in 2001 was less than recommended, and improvement is needed to reach national health objectives.

To obtain the complete text of the article online, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5143a2.htm

To obtain a camera-ready (PDF format) copy of this issue of MMWR, go to: http://www.cdc.gov/mmwr/PDF/wk/mm5143.pdf
----------------------------------------------------------

Back to Top

(9 of 9)
November 4, 2002
FOURTH NATIONAL HARM REDUCTION CONFERENCE, "TAKING DRUG USERS SERIOUSLY," SET FOR DECEMBER 1-4

The Fourth National Harm Reduction Conference, "Taking Drug Users Seriously," will be held in Seattle on December 1-4. The major themes include housing, overdose, mental health, prison and criminal justice, and HIV.

For conference information, go to: http://www.harmreduction.org/conference/4thnatlconf.html

For additional information, call (212) 213-6376 or email hrc@harmreduction.org

 

Immunization Action Coalition1573 Selby AvenueSt. Paul MN 55104
E-mail: admin@immunize.org Web: http://www.immunize.org/
Tel: (651) 647-9009Fax: (651) 647-9131

This page was updated on November 4, 2002